Results
1 -
10 of
14Imaging Mass Spectrometry for Visualization of Drug and Endogenous Metabolite Distribution: Toward In Situ Pharmacometabolomes, Journal of Neuroimmune Pharmacology Combinations of Hypoxia-Targeting Compounds and Radiation-Activated Prodrugs with Ionizing Radiation, Multimodal Concepts for Integration of Cytotoxic Drugs Cancer Hypoxia and the Tumour Microenvironment as Effectors of Cancer Metabolism, Correlation-based network analysis of cancer metabolism Modelling of Tirapazamine Effects on Solid Tumour Morphology, 5th International Conference on Practical Applications of Computational Biology & Bioinformatics (PACBB 2011) Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent, Cancer and Metastasis Reviews Royal academy of medicine in ireland section of biomedical sciences, Irish Journal of Medical Science Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs, Cancer Chemotherapy and Pharmacology Dissemination via the lymphatic or angiogenic route impacts the pathology, microenvironment and hypoxia-related drug response of lung metastases, Clinical & Experimental Metastasis New Developments in Targeted Therapy for Soft Tissue Sarcoma, Current Oncology Reports Targeting hypoxic tumour cells to overcome metastasis, BMC Cancer